Simplyhealth is a health solutions company that has provided healthcare plans since 1872 and invests in predictive and preventative healthcare services.
Rupert brings commercial and strategic experience from healthcare, venture capital, and board roles. He currently serves as Chief Commercial Officer at BML and chairs the Royal Humane Society.
The financing will support manufacturing expansion and commercial launch preparation ahead of clinical trials.
"For decades, continuous monitoring has been held back by the same legacy technology. This is about to change. We’re thrilled to be partnering with Ascensia, a global powerhouse in the space, to deliver, as a first step, something radically better to millions of people with diabetes,"
AlbionVC led the Series A round for the healthcare-as-a-service provider, with backing from Simplyhealth Ventures, Exceptional Ventures, Cornerstone VC, and BBI.
The oversubscribed round was backed by MMC Ventures, Molten VC, Simplyhealth Ventures, and KHP Ventures.
"Today’s announcement of our heavily oversubscribed investment round is a major endorsement of our incredible technology and our journey to date. We are delighted to see such healthy interest in our vision of revolutionising access to screening from the investment community and we’re thrilled to have Molten Ventures, MMC Ventures, and Simplyhealth Ventures investing. The inclusion of KHP Ventures as a fund backed by NHS institutions is a clear signal of our NHS traction and alignment with overall NHS priorities – we couldn’t be happier that they’re investing in our journey."
MMC Ventures and Hambro Perks led the round to support team growth and international expansion.
"Musculoskeletal health conditions have been a societal problem across the world for decades, and our data shows that rates of pain have massively increased since the rise of hybrid working. With this new funding, we’ll be able to continue our growth to reduce the financial and health costs for employers and their teams."
The investment round was co-led by Aviva Ventures, YZR Capital, Oxford Capital, Triple Point Ventures and Simplyhealth Ventures to fund US expansion and new product development.
"Our investment in Scan.com is a statement of our intent to invest in promising young digital and tech firms – they are growing rapidly, have a unique customer proposition and are already leading the way on medical imaging services in the UK. We are really excited to support Scan.com’s development and growth."